Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Cancer Res. 2017 Jul 1;77(13):3718. doi: 10.1158/0008-5472.CAN-17-0556

Retraction: Molecular Mechanism of MART-1+/A*0201+ Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor–CTL Interaction

PMCID: PMC5982110  NIHMSID: NIHMS969889  PMID: 28674203

The article titled “Molecular Mechanism of MART-1+/A*0201+ Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor–CTL Interaction,” which was published in the February 15, 2011, issue of Cancer Research (1), is being retracted at the request of the University of California, Los Angeles (Los Angeles, CA). Following an institutional review, it was determined that data used in some of the figures cannot be supported; specifically, the 3- and 6-hour bands in Fig. 4C are duplicates of the M329-actin bands in Fig. 4A. To ensure that the research record is correct, the institution has requested that the article be retracted. The authors have been made aware of this retraction.

References

  • 1.Jazirehi AR, Baritaki S, Koya RC, Bonavida B, Economou JS. Molecular mechanism of MART-1+/ A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor–CTL interaction. Cancer Res. 2011;71:1406–17. doi: 10.1158/0008-5472.CAN-10-1296. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

RESOURCES